Chemours Stock Price, News & Analysis (NYSE:CC)

$51.00 -1.47 (-2.80 %)
(As of 01/17/2018 01:07 PM ET)
Previous Close$52.47
Today's Range$50.74 - $52.96
52-Week Range$23.92 - $58.08
Volume1.64 million shs
Average Volume1.65 million shs
Market Capitalization$9.64 billion
P/E Ratio35.17
Dividend Yield0.23%
BetaN/A

About Chemours (NYSE:CC)

Chemours logoThe Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries. It delivers customized solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, industrial, mining and oil refining. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide. As of December 31, 2016, the Company operates 26 production facilities located in 10 countries.

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Commodity Chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:CC
CUSIPN/A
Phone+1-302-7731000

Debt

Debt-to-Equity Ratio5.07%
Current Ratio2.19%
Quick Ratio1.63%

Price-To-Earnings

Trailing P/E Ratio35.1724137931035
Forward P/E Ratio13.97
P/E Growth0.68

Sales & Book Value

Annual Sales$5.40 billion
Price / Sales1.75
Cash Flow$2.62 per share
Price / Cash19.43
Book Value$0.57 per share
Price / Book89.47

Profitability

Trailing EPS$1.45
Net Income$7 million
Net Margins4.86%
Return on Equity116.80%
Return on Assets8.10%

Miscellaneous

Employees7,000
Outstanding Shares185,160,000

Chemours (NYSE:CC) Frequently Asked Questions

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours announced a quarterly dividend on Friday, December 1st. Investors of record on Thursday, February 15th will be given a dividend of $0.17 per share on Thursday, March 15th. This represents a $0.68 annualized dividend and a dividend yield of 1.33%. The ex-dividend date is Wednesday, February 14th. This is a positive change from Chemours's previous quarterly dividend of $0.03. View Chemours' Dividend History.

How will Chemours' stock buyback program work?

Chemours announced that its Board of Directors has initiated a stock repurchase program on Monday, December 4th 2017, which permits the company to repurchase $500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's management believes its stock is undervalued.

How were Chemours' earnings last quarter?

Chemours Co (NYSE:CC) announced its quarterly earnings data on Thursday, November, 2nd. The specialty chemicals company reported $1.12 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.01 by $0.11. The specialty chemicals company earned $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. Chemours had a net margin of 4.86% and a return on equity of 116.80%. The business's quarterly revenue was up 13.3% on a year-over-year basis. During the same period in the prior year, the business earned $0.61 EPS. View Chemours' Earnings History.

When will Chemours make its next earnings announcement?

Chemours is scheduled to release their next quarterly earnings announcement on Wednesday, February, 21st 2018. View Earnings Estimates for Chemours.

Where is Chemours' stock going? Where will Chemours' stock price be in 2018?

7 brokers have issued twelve-month price targets for Chemours' stock. Their predictions range from $55.00 to $66.00. On average, they expect Chemours' share price to reach $57.86 in the next twelve months. View Analyst Ratings for Chemours.

What are Wall Street analysts saying about Chemours stock?

Here are some recent quotes from research analysts about Chemours stock:

  • 1. According to Zacks Investment Research, "Chemours Company is involved in chemical business. It operating segment consists of Titanium Technologies, Fluoroproducts and Chemical Solutions. Titanium Technologies segment produces titanium dioxide and premium white pigment. Fluoroproducts segment provides fluoroproducts, refrigerants and industrial fluoropolymer resins. Chemical Solutions segment provides industrial and specialty chemicals. The company's brand consists of Teflon(R), Ti-Pure(R), Krytox(R) Viton(R), Opteon(R) and Nafion(R). Chemours Company is headquartered in Wilmington. " (12/6/2017)
  • 2. Jefferies Group LLC analysts commented, "Clarity on the PFOA liability significantly reduces Chemours' risk profile, and the stock has responded accordingly. In our view, the next 18 months are a story of delivering on cost controls, leveraging and extending Opteon, and managing TiO2 as the industry shifts from a restock cycle to a potential improvement in underlying demand." (2/15/2017)

Who are some of Chemours' key competitors?

Who are Chemours' key executives?

Chemours' management team includes the folowing people:

  • Richard H. Brown, Independent Chairman of the Board (Age 69)
  • Mark P. Vergnano, President, Chief Executive Officer, Director (Age 59)
  • Mark E. Newman, Chief Financial Officer, Senior Vice President (Age 53)
  • Paul Kirsch, President - Fluoroproducts (Age 53)
  • Christian W. Siemer, President - Chemical Solutions (Age 58)
  • E. Bryan Snell, President - Titanium Technologies (Age 60)
  • Elizabeth Albright, Senior Vice President - Human Resources (Age 50)
  • Erich Parker, Vice President of Corporate Communications, Chief Brand Officer (Age 65)
  • David Charles Shelton, Corporate Secretary and General Counsel (Age 53)
  • Curtis V. Anastasio, Independent Director (Age 60)

Who owns Chemours stock?

Chemours' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Bank of Montreal Can (0.03%), Louisiana State Employees Retirement System (0.03%), Aurora Investment Counsel (0.02%), Sheets Smith Wealth Management (0.01%), Nisa Investment Advisors LLC (0.01%) and DnB Asset Management AS (0.01%). Company insiders that own Chemours stock include Amy Trojanowski, Bradley J Bell, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Paul Kirsch, Richard H Brown and Stephen D Newlin. View Institutional Ownership Trends for Chemours.

Who sold Chemours stock? Who is selling Chemours stock?

Chemours' stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Sheets Smith Wealth Management and Louisiana State Employees Retirement System. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman and Paul Kirsch. View Insider Buying and Selling for Chemours.

Who bought Chemours stock? Who is buying Chemours stock?

Chemours' stock was acquired by a variety of institutional investors in the last quarter, including Aurora Investment Counsel, DnB Asset Management AS and Nisa Investment Advisors LLC. Company insiders that have bought Chemours stock in the last two years include Bradley J Bell, Mark Newman, Richard H Brown and Stephen D Newlin. View Insider Buying and Selling for Chemours.

How do I buy Chemours stock?

Shares of Chemours can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemours' stock price today?

One share of Chemours stock can currently be purchased for approximately $51.00.

How big of a company is Chemours?

Chemours has a market capitalization of $9.64 billion and generates $5.40 billion in revenue each year. The specialty chemicals company earns $7 million in net income (profit) each year or $1.45 on an earnings per share basis. Chemours employs 7,000 workers across the globe.

How can I contact Chemours?

Chemours' mailing address is 1007 Market St, WILMINGTON, DE 19898-1100, United States. The specialty chemicals company can be reached via phone at +1-302-7731000 or via email at [email protected]


MarketBeat Community Rating for Chemours (CC)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  161 (Vote Outperform)
Underperform Votes:  194 (Vote Underperform)
Total Votes:  355
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Chemours (NYSE:CC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.862.863.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $57.86$57.86$51.83$40.00
Price Target Upside: 25.06% upside25.06% upside16.72% upside9.11% downside

Chemours (NYSE:CC) Consensus Price Target History

Price Target History for Chemours (NYSE:CC)

Chemours (NYSE:CC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/6/2017BarclaysReiterated RatingBuy$60.00LowView Rating Details
12/6/2017Goldman Sachs GroupDowngradeBuy -> Neutral$55.00MediumView Rating Details
12/4/2017Jefferies GroupBoost Price TargetBuy$66.00HighView Rating Details
8/10/2017ArgusReiterated RatingBuy$50.00 -> $55.00HighView Rating Details
8/4/2017JPMorgan Chase & Co.Boost Price TargetOverweight$55.00LowView Rating Details
8/4/2017CitigroupBoost Price TargetBuy$45.00 -> $59.00HighView Rating Details
5/15/2017Susquehanna BancsharesBoost Price TargetPositive$45.00 -> $55.00LowView Rating Details
(Data available from 1/17/2016 forward)

Earnings

Chemours (NYSE:CC) Earnings History and Estimates Chart

Earnings by Quarter for Chemours (NYSE:CC)

Chemours (NYSE CC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/13/2018$0.97N/AView Earnings Details
11/2/2017Q3 2017$1.01$1.12$1.59 billion$1.58 billionViewN/AView Earnings Details
8/2/2017Q2 2017$0.85$0.87$1.49 billion$1.59 billionViewListenView Earnings Details
5/1/2017Q1 2017$0.50$0.75$1.32 billion$1.44 billionViewListenView Earnings Details
2/15/2017Q416$0.29$0.08$1.24 billion$1.30 billionViewN/AView Earnings Details
11/6/2016Q3 2016$0.25$0.61$1.29 billion$1.40 billionViewN/AView Earnings Details
8/8/2016Q216$0.17$0.27$1.42 billion$1.38 billionViewN/AView Earnings Details
5/2/2016Q116$0.02$0.06$1.27 billion$1.30 billionViewN/AView Earnings Details
2/23/2016Q415$0.09$0.03$1.36 billion$1.40 billionViewListenView Earnings Details
11/5/2015Q315$0.26$0.40$1.52 billion$1.49 billionViewN/AView Earnings Details
8/6/2015Q215$0.33$0.24$1.53 billion$1.50 billionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Chemours (NYSE:CC) Earnings Estimates

Current Year EPS Consensus Estimate: $3.65 EPS
Next Year EPS Consensus Estimate: $5 EPS

Dividends

Chemours (NYSE:CC) Dividend Information

Next Dividend:3/15/2018
Annual Dividend:$0.12
Dividend Yield:0.24%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:8.28% (Trailing 12 Months of Earnings)
3.29% (Based on This Year's Estimates)
2.40% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Chemours (NYSE:CC)

Chemours (NYSE:CC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/1/2017Quarterly$0.171.43%2/14/20182/15/20183/15/2018
11/7/2017quarterly$0.030.24%11/17/201711/20/201712/15/2017
8/2/2017quarterly$0.030.25%8/15/20178/17/20179/15/2017
4/27/2017quarterly$0.030.3%5/15/20175/17/20176/15/2017
2/14/2017quarterly$0.030.37%2/23/20172/27/20173/15/2017
11/2/2016quarterly$0.030.72%11/15/201611/17/201612/15/2016
8/3/2016quarterly$0.031.34%8/15/20168/17/20169/15/2016
4/27/2016quarterly$0.031.27%5/13/20165/17/20166/15/2016
2/23/2016quarterly$0.032.44%3/9/20163/11/20163/31/2016
9/1/2015quarterly$0.031.38%11/10/201511/13/201512/14/2015
7/24/2015special$0.557/30/20158/3/20159/11/2015
(Data available from 1/1/2013 forward)

Insider Trades

Chemours (NYSE CC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.14%
Institutional Ownership Percentage: 74.36%
Insider Trades by Quarter for Chemours (NYSE:CC)
Institutional Ownership by Quarter for Chemours (NYSE:CC)

Chemours (NYSE CC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/13/2017Christian W. SiemerInsiderSell15,088$47.37$714,718.56View SEC Filing  
11/6/2017E Bryan SnellInsiderSell11,878$53.25$632,503.5063,063View SEC Filing  
10/13/2017David C SheltonSVPSell5,908$56.01$330,907.0847,356View SEC Filing  
10/10/2017David C SheltonSVPSell13,397$55.00$736,835.00View SEC Filing  
10/5/2017David C SheltonSVPSell19,000$53.68$1,019,920.00View SEC Filing  
9/5/2017E Bryan SnellInsiderSell13,000$49.35$641,550.00View SEC Filing  
8/31/2017David C. SheltonSVPSell13,337$48.48$646,577.76View SEC Filing  
8/11/2017Amy TrojanowskiVPSell2,500$46.03$115,075.00View SEC Filing  
8/11/2017E Bryan SnellInsiderSell10,000$46.24$462,400.00View SEC Filing  
6/5/2017Paul KirschInsiderSell19,036$41.42$788,471.12View SEC Filing  
5/16/2017Erich ParkerVPSell4,908$45.53$223,461.24View SEC Filing  
5/5/2017Mark NewmanVPSell22,781$39.83$907,367.23View SEC Filing  
5/3/2017Richard H. BrownDirectorBuy2,500$39.10$97,750.00View SEC Filing  
5/13/2016Mark NewmanCFOBuy2,800$9.71$27,188.00108,533View SEC Filing  
5/4/2016Bradley J BellDirectorBuy10,000$9.65$96,500.0021,747View SEC Filing  
2/26/2016Stephen D. NewlinDirectorBuy10,000$4.94$49,400.00View SEC Filing  
11/23/2015Thierry Fj VanlanckerInsiderBuy15,000$6.00$90,000.00190,022View SEC Filing  
9/14/2015E Bryan SnellInsiderBuy8,000$8.89$71,120.0022,051View SEC Filing  
9/11/2015Amy TrojanowskiVPBuy5,400$9.24$49,896.0011,982View SEC Filing  
9/10/2015Christian W SiemerInsiderBuy10,100$9.39$94,839.0031,843View SEC Filing  
9/9/2015Mark NewmanCFOBuy10,600$9.32$98,792.00114,109View SEC Filing  
9/8/2015Christian W SiemerInsiderBuy11,000$9.11$100,210.0021,743View SEC Filing  
9/4/2015David C SheltonSVPBuy5,000$9.00$45,000.0013,183View SEC Filing  
9/4/2015Mark P VergnanoCEOBuy72,600$9.25$671,550.00321,337View SEC Filing  
9/4/2015Stephen D. NewlinDirectorBuy7,000$9.18$64,260.0016,680View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Chemours (NYSE CC) News Headlines

Source:
DateHeadline
Interesting CC Put And Call Options For February 16th - Nasdaq.com - NasdaqInteresting CC Put And Call Options For February 16th - Nasdaq.com - Nasdaq
www.nasdaq.com - January 2 at 11:17 PM
How Financially Strong Is The Chemours Company (NYSE:CC)?How Financially Strong Is The Chemours Company (NYSE:CC)?
finance.yahoo.com - December 28 at 5:28 AM
Chemours Co (CC) Given Average Rating of "Buy" by BrokeragesChemours Co (CC) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - December 26 at 2:38 PM
Chemours to Increase Fluoropolymer PricesChemours to Increase Fluoropolymer Prices
finance.yahoo.com - December 26 at 9:19 AM
Chemours Announces Fluoropolymer Price IncreaseChemours Announces Fluoropolymer Price Increase
finance.yahoo.com - December 21 at 9:50 AM
Chemours Breaks Ground on New State-of-the-Art Innovation Center, The Chemours Discovery Hub, on the University of Delawares Science Technology and Advanced Research CampusChemours Breaks Ground on New State-of-the-Art Innovation Center, The Chemours Discovery Hub, on the University of Delaware's Science Technology and Advanced Research Campus
www.prnewswire.com - December 18 at 1:52 PM
Contrasting Ingevity (NGVT) and Chemours (CC)Contrasting Ingevity (NGVT) and Chemours (CC)
www.americanbankingnews.com - December 18 at 7:50 AM
Chemours Co (CC) Insider Sells $714,718.56 in StockChemours Co (CC) Insider Sells $714,718.56 in Stock
www.americanbankingnews.com - December 15 at 11:34 PM
Chemours (CC) Stock Rating Lowered by Zacks Investment ResearchChemours (CC) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - December 6 at 7:11 PM
Barclays Reiterates "Buy" Rating for Chemours (CC)Barclays Reiterates "Buy" Rating for Chemours (CC)
www.americanbankingnews.com - December 6 at 11:58 AM
3 Embarrassingly Low Dividend Stocks3 Embarrassingly Low Dividend Stocks
finance.yahoo.com - December 6 at 9:59 AM
Goldman Sachs Group Lowers Chemours (CC) to NeutralGoldman Sachs Group Lowers Chemours (CC) to Neutral
www.americanbankingnews.com - December 6 at 8:36 AM
Analysts Offer Predictions for Chemours Company (The)s FY2017 Earnings (CC)Analysts Offer Predictions for Chemours Company (The)'s FY2017 Earnings (CC)
www.americanbankingnews.com - December 6 at 7:34 AM
Chemours’ stock drops as tax-inspired profit-taking offsets ‘attractive’ reform benefitsChemours’ stock drops as tax-inspired profit-taking offsets ‘attractive’ reform benefits
finance.yahoo.com - December 5 at 10:31 AM
These 3 Stocks Are Priced for Perfection -- Can They Deliver?These 3 Stocks Are Priced for Perfection -- Can They Deliver?
finance.yahoo.com - December 5 at 10:31 AM
Zacks.com highlights: Home Depot, Primerica, Broadridge Financial Solutions and ChemoursZacks.com highlights: Home Depot, Primerica, Broadridge Financial Solutions and Chemours
finance.yahoo.com - December 5 at 10:31 AM
Equities Analysts Set Expectations for Chemours Company (The)s Q4 2017 Earnings (CC)Equities Analysts Set Expectations for Chemours Company (The)'s Q4 2017 Earnings (CC)
www.americanbankingnews.com - December 5 at 9:04 AM
Chemours (CC) Board Authorizes Share Repurchase PlanChemours (CC) Board Authorizes Share Repurchase Plan
www.americanbankingnews.com - December 4 at 11:10 AM
Chambers Cogeneration Ltd. Partnership -- Moodys affirms Chambers Cogeneration at Baa3, stable; following planned change in ownershipChambers Cogeneration Ltd. Partnership -- Moody's affirms Chambers Cogeneration at Baa3, stable; following planned change in ownership
finance.yahoo.com - December 4 at 9:49 AM
Chemours (CC) Price Target Raised to $66.00 at Jefferies GroupChemours (CC) Price Target Raised to $66.00 at Jefferies Group
www.americanbankingnews.com - December 4 at 8:52 AM
Chemours (CC) Offers Outlook at Investor Day and Approves $500M Buyback - StreetInsider.comChemours (CC) Offers Outlook at Investor Day and Approves $500M Buyback - StreetInsider.com
www.streetinsider.com - December 2 at 4:53 PM
Heres Why You Should Invest in Chemours (CC) Stock Now - NasdaqHere's Why You Should Invest in Chemours (CC) Stock Now - Nasdaq
www.nasdaq.com - December 2 at 4:53 PM
Cemours first ever investor dayCemours first ever investor day
finance.yahoo.com - December 2 at 9:31 AM
Chemours Company (The) (CC) Given Average Recommendation of "Buy" by AnalystsChemours Company (The) (CC) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - December 1 at 7:46 PM
Chemours (CC) Offers Outlook at Investor Day and Approves $500M BuybackChemours (CC) Offers Outlook at Investor Day and Approves $500M Buyback
www.streetinsider.com - December 1 at 5:08 PM
The Chemours Company Hosts First Investor DayThe Chemours Company Hosts First Investor Day
finance.yahoo.com - December 1 at 5:08 PM
Chemours stock erases sharp early loss to close higher after 5-fold dividend hike, new stock buyback planChemours stock erases sharp early loss to close higher after 5-fold dividend hike, new stock buyback plan
finance.yahoo.com - December 1 at 5:08 PM
Chemours rang the closing bell at the New York Stock ExchangeChemours rang the closing bell at the New York Stock Exchange
finance.yahoo.com - December 1 at 5:08 PM
Heres Why You Should Invest in Chemours (CC) Stock NowHere's Why You Should Invest in Chemours (CC) Stock Now
finance.yahoo.com - November 30 at 10:18 AM
Here's Why You Should Invest in Chemours (CC) Stock NowHere's Why You Should Invest in Chemours (CC) Stock Now
finance.yahoo.com - November 30 at 10:18 AM
Chemours (CC) versus Olin (OLN) Financial AnalysisChemours (CC) versus Olin (OLN) Financial Analysis
www.americanbankingnews.com - November 30 at 5:56 AM
Top Ranked Growth Stocks to Buy for November 28thTop Ranked Growth Stocks to Buy for November 28th
www.zacks.com - November 28 at 8:22 AM
Top Ranked Growth Stocks to Buy for November 24thTop Ranked Growth Stocks to Buy for November 24th
www.zacks.com - November 24 at 11:17 AM
Chemours Company (The) (CC) versus Its Rivals Head to Head AnalysisChemours Company (The) (CC) versus Its Rivals Head to Head Analysis
www.americanbankingnews.com - November 22 at 9:04 PM
Top Ranked Growth Stocks to Buy for November 21stTop Ranked Growth Stocks to Buy for November 21st
finance.yahoo.com - November 21 at 5:13 PM
The Chemours Co. : CC-US: Dividend Analysis : November 20th, 2017 (record date) : By the numbers : November 20, 2017The Chemours Co. : CC-US: Dividend Analysis : November 20th, 2017 (record date) : By the numbers : November 20, 2017
finance.yahoo.com - November 20 at 6:09 PM
Reviewing PQ Group Holdings (PQG) and Chemours Company (The) (CC)Reviewing PQ Group Holdings (PQG) and Chemours Company (The) (CC)
www.americanbankingnews.com - November 19 at 1:16 PM
North Carolina regulator revokes Chemours process wastewater permit - Seeking AlphaNorth Carolina regulator revokes Chemours' process wastewater permit - Seeking Alpha
seekingalpha.com - November 18 at 8:37 AM
Chemours Company (CC) Ex-Dividend Date Scheduled for November 17, 2017 - NasdaqChemours Company (CC) Ex-Dividend Date Scheduled for November 17, 2017 - Nasdaq
www.nasdaq.com - November 16 at 3:22 PM
Top Ranked Growth Stocks to Buy for November 15thTop Ranked Growth Stocks to Buy for November 15th
finance.yahoo.com - November 16 at 12:30 PM
FY2017 EPS Estimates for Chemours Company (The) Boosted by Analyst (CC)FY2017 EPS Estimates for Chemours Company (The) Boosted by Analyst (CC)
www.americanbankingnews.com - November 15 at 6:58 AM
Zacks.com highlights: Chemours, POSCO, Ecopetrol S.A. and Micron TechnologyZacks.com highlights: Chemours, POSCO, Ecopetrol S.A. and Micron Technology
finance.yahoo.com - November 14 at 5:28 PM
FY2018 Earnings Estimate for Chemours Company (The) (CC) Issued By Jefferies GroupFY2018 Earnings Estimate for Chemours Company (The) (CC) Issued By Jefferies Group
www.americanbankingnews.com - November 14 at 12:12 PM
Chemours Company (The) (CC) & Its Competitors Head-To-Head ContrastChemours Company (The) (CC) & Its Competitors Head-To-Head Contrast
www.americanbankingnews.com - November 14 at 1:32 AM
Chemours to Pay a 4Q17 DividendChemours to Pay a 4Q17 Dividend
finance.yahoo.com - November 13 at 11:24 PM
Head-To-Head Analysis: Chemours Company (The) (CC) & Methanex Corporation (MEOH)Head-To-Head Analysis: Chemours Company (The) (CC) & Methanex Corporation (MEOH)
www.americanbankingnews.com - November 13 at 5:15 AM
Earnings Review and Free Research Report: Kraton’s Adjusted EPS soared 139.6%Earnings Review and Free Research Report: Kraton’s Adjusted EPS soared 139.6%
finance.yahoo.com - November 10 at 10:21 AM
Chemours Company (The) (CC) Upgraded to "Buy" at Zacks Investment ResearchChemours Company (The) (CC) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - November 9 at 6:28 PM
E Bryan Snell Sells 11,878 Shares of Chemours Company (The) (CC) StockE Bryan Snell Sells 11,878 Shares of Chemours Company (The) (CC) Stock
www.americanbankingnews.com - November 9 at 12:32 AM
The Chemours Co. breached its 50 day moving average in a Bearish Manner : CC-US : November 8, 2017The Chemours Co. breached its 50 day moving average in a Bearish Manner : CC-US : November 8, 2017
finance.yahoo.com - November 8 at 8:03 PM

SEC Filings

Chemours (NYSE:CC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Chemours (NYSE:CC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Chemours (NYSE CC) Stock Chart for Wednesday, January, 17, 2018

Loading chart…

This page was last updated on 1/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.